Effects of Muscarinic M1 Receptor Blockade on Cocaine-Induced Elevations of Brain Dopamine Levels and Locomotor Behavior in Rats
Authors:
- Gianluigi TandaGTGianluigi Tanda
- Aaron L. EbbsAEAaron L. Ebbs
- Theresa A. KopajticTKTheresa A. Kopajtic
- Lyn M. EliasLELyn M. Elias
- Bettye L. CampbellBCBettye L. Campbell
- Amy H. NewmanANAmy H. Newman
- Jonathan L. KatzJKJonathan L. Katz
- 1 April 2007
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 321 (1) , 334-344
Abstract
Cholinergic muscarinic systems have been shown to influence dopaminergic function in the central nervous system. In addition, previous studies of benztropine analogs that inhibit dopamine uptake and show antagonism at muscarinic receptors show these drugs to be less effective than cocaine in producing its various prototypic effects such as locomotor stimulation. Because previous pharmacological studies on these topics have used nonselective M1 antagonists, we examined the interactions of preferential M1 muscarinic antagonists and cocaine. Dose-dependent increases in extracellular levels of dopamine in selected brain areas, the nucleus accumbens (NAc) shell and core, and the prefrontal cortex, were produced by cocaine but not by the preferential M1 antagonists telenzepine and trihexyphenidyl. When administered with cocaine, however, both M1 antagonists dose-dependently increased the effects of cocaine on dopamine in the NAc shell, and these effects were selective in that they were not obtained in the NAc core or in the prefrontal cortex. Telenzepine also increased locomotor activity, although the effect was small compared with that of cocaine. The locomotor stimulant effects of trihexyphenidyl, in contrast, approached those of cocaine. Telenzepine attenuated, whereas trihexyphenidyl enhanced the locomotor stimulant effects of cocaine, with neither drug facilitating cocaine-induced stereotypy. The present results indicate that preferential antagonist effects at muscarinic M1 receptors do not uniformly alter all of the effects of cocaine, nor do they explain the differences in effects of cocaine and benztropine analogs, and that the alterations in dopamine levels in the NAc shell do not predict the behavioral effects of the interactions with cocaine.Keywords
This publication has 40 references indexed in Scilit:
- Structure–activity relationship of trihexyphenidyl analogs with respect to the dopamine transporter in the on going search for a cocaine inhibitorEuropean Journal of Medicinal Chemistry, 2005
- Cholinergic interneurons of the nucleus accumbens and dorsal striatum are activated by the self-administration of cocaineNeuroscience, 2003
- Role for M5 muscarinic acetylcholine receptors in cocaine addictionJournal of Neuroscience Research, 2003
- Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient miceProceedings of the National Academy of Sciences, 2001
- Activation of the mesocorticolimbic dopaminergic system by stimulation of muscarinic cholinergic receptors in the ventral tegmental area.Psychopharmacology, 2000
- Effect of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism: an in vivo microdialysis study comparing normal and 6-hydroxydopamine-lesioned ratsBrain Research, 1993
- Low doses of ethanol activate dopaminergic neurons in the ventral tegmental areaBrain Research, 1985
- Pharmacological evidence for selective inhibition of gastric acid secretion by telenzepine, a new antimuscarinic drugEuropean Journal of Pharmacology, 1985
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973
- Augmentation of the behavioral effects of amphetamine by scopolaminePsychopharmacology, 1961